Best Practice & Research Clinical Endocrinology & Metabolism
Volume 21, Issue 3 , Pages 480-495 , September 2007

Tumor risk in disorders of sex development (DSD)

  • Leendert H.J. Looijenga (Professor, Biologist, Head Research)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel./Fax: +31 10 4088329/65.

References 

  1. Hughes IA, Houk C, Ahmed SF, et al. Consensus statement on management of intersex disorders. Archives of Disease in Childhood. 2006;91:554–563
  2. Oosterhuis J, Looijenga L. Testicular germ-cell tumours in a broader perspective. Nature Reviews. Cancer. 2005;5:210–222
  3. Woodward PJ, Heidenreich A, Looijenga LHJ, et al. Testicular germ cell tumors. In:  Eble JN,  Sauter G,  Epstein JI editor. World Health Organization Classification of Tumours. Pathology and Genetics of the Urinary System and Male Genital Organs. Sesterhann IA. Lyon: IARC Press; 2004;p. 217–278
  4. Walsh TJ, Grady RW, Porter MP, et al. Incidence of testicular germ cell cancers in U.S. children: SEER program experience 1973 to 2000. Urology. 2006;68:402–405discussion 405
  5. Bray F, Richiardi L, Ekbom A, et al. Trends in testicular cancer incidence and mortality in 22 European countries: Continuing increases in incidence and declines in mortality. International Journal of Cancer. 2006;118:3099–3111
  6. Skakkebaek NE. Testicular dysgenesis syndrome: new epidemiological evidence. International Journal of Andrology. 2004;27:189–191
  7. Honecker F, Stoop H, Mayer F, et al. Germ cell lineage differentiation in nonseminomatous germ cell tumors. The Journal of Pathology. 2006;208:395–400
  8. Mostert MC, Rosenberg C, Stoop H, et al. Comparative genomic and in situ hybridization of germ cell tumors of the infantile testis. Laboratory Investigation. 2000;80:1055–1064
  9. Veltman I, Van Asseldonk M, Schepens M, et al. A novel case of infantile sacral teratoma and a constitutional t(12;15) (q13;q25) pat. Cancer Genetics and Cytogenetics. 2002;136:17–22
  10. Veltman I, Schepens MT, Looijenga LHJ, et al. Germ cell tumours in neonates and infants: a distinct subgroup. APMIS. 2003;111:152–160
  11. Veltman I, Veltman J, Jeanssen I, et al. Identification of recurrent chromosomal aberations in germ cell tumors of neonates and infants using genome-wide array-based comparative genomic hyrbidization. Genes, Chromosomes & Cancer. 2005;43:367–376
  12. Stallock J, Molyneaux K, Schaible K, et al. The pro-apoptotic gene Bax is required for the death of ectopic primordial germ cells during their migration in the mouse embryo. Development. 2003;130:6589–6597
  13. Lawson KA, Dunn NR, Roelen BA, et al. Bmp4 is required for the generation of primordial germ cells in the mouse embryo. Genes & Development. 1999;13:424–436
  14. Anderson R, Copeland TK, Scholer H, et al. The onset of germ cell migration in the mouse embryo. Mechanisms of Development. 2000;91:61–68
  15. Wylie C. Germ cells. Cell. 1999;96:165–174
  16. Niwa H, Miyazaki J, Smith AG. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nature Genetics. 2000;24:372–376
  17. Wilhelm D, Koopman P. The makings of maleness: towards an integrated view of male sexual development. Nature Reviews. Genetics. 2006;7:620–631
  18. Honecker F, Stoop H, de Krijger RR, et al. Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells. The Journal of Pathology. 2004;203:849–857
  19. Gidekel S, Pizov G, Bergman Y, et al. Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer Cell. 2003;4:361–370
  20. Brennan J, Capel B. One tissue, two fates: molecular genetic events that underlie testis versus ovary development. Nature Reviews. Genetics. 2004;5:509–521
  21. Stoop H, Honecker F, De Krijger R, et al. Differentiation and development of human female germ cells during prenatal gonadogenesis: an immunohistochemical study. Human Reproduction (Oxford, England). 2005;20:1466–1476
  22. Rajpert-De Meyts E, Hanstein R, Jorgensen N, et al. Developmental expression of POU5F1 (OCT-3/4) in normal and dysgenetic human gonads. Human Reproduction (Oxford, England). 2004;19:1338–1344
  23. Surani MA. Imprinting and the initiation of gene silencing in the germ line. Cell. 1998;93:309–312
  24. Walter J, Paulsen M. Imprinting and disease. Seminars in Cell & Developmental Biology. 2003;14:101–110
  25. Szabo PE, Mann JR. Biallelic expression of imprinted genes in the mouse germ line: Implications for erasure, establishment, and mechanisms of genomic imprinting. Genes & Development. 1995;9:1857–1868
  26. Kerjean A, Dupont JM, Vasseur C, et al. Establishment of the paternal methylation imprint of the human H19 and MEST/PEG1 genes during spermatogenesis. Human Molecular Genetics. 2000;9:2183–2187
  27. Skakkebæk NE. Possible carcinoma-in-situ of the testis. Lancet. 1972;516–517
  28. Dieckmann KP, Kulejewski M, Pichlmeier U, et al. Diagnosis of contralateral testicular intraepithelial neoplasia (TIN) in patients with testicular germ cell cancer: systematic two-site biopsies are more sensitive than a single random biopsy. European Urology. 2007;51:175–185
  29. Almstrup K, Ottesen AM, Sonne SB, et al. Genomic and gene expression signature of the pre-invasive testicular carcinoma in situ. Cell and Tissue Research. 2005;322:159–165
  30. Matin MM, Walsh JR, Gokhale PJ, et al. Specific knockdown of Oct4 and beta2-microglobulin expression by RNA interference in human embryonic stem cells and embryonic carcinoma cells. Stem Cells. 2004;22:659–668
  31. Kehler J, Tolkunova E, Koschorz B, et al. Oct4 is required for primordial germ cell survival. EMBO Reports. 2004;5:1078–1083
  32. Cheng L, Sung MT, Cossu-Rocca P, et al. OCT4: biological functions and clinical applications as a marker of germ cell neoplasia. The Journal of Pathology. 2007;211:1–9
  33. De Jong J, Looijenga LHJ. Stem cell marker OCT3/4 in tumor biology and germ cell tumor diagnostics: history and future. OCT3/4 in oncogenesis. Critical Reviews in Oncogenesis. 2006;12:171–203
  34. De Jong J, Stoop J, Dohle GR, et al. Diagnostic value of OCT3/4 for pre-invasive and invasive testicular germ cell tumors. The Journal of Pathology. 2005;206:242–249
  35. Looijenga LHJ, Stoop H, De Leeuw PJC, et al. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Research. 2003;63:2244–2250
  36. Cools M, Van Aerde K, Kersemaekers AM, et al. From gonadal maturation delay towards carcinoma in situ of the testes in patients with undervirilization syndromes. The Journal of Clinical Endocrinology and Metabolism. 2005;90:5295–5303
  37. Kersemaekers AM, Honecker F, Cools M, et al. Identification of germ cells at risk for neoplastic transformation in gonadoblastomas: An immunohistochemical study for OCT3/4 and TSPY. Human Pathology. 2005;36:512–521
  38. Cools M, Drop SL, Wolffenbuttel KP, et al. Germ cell tumors in the intersex gonad: Old paths, new directions, moving frontiers. Endocrine Reviews. 2006;27:468–484
  39. Scully RE. Gonadoblastoma/A review of 74 cases. Cancer. 1970;25:1340–1356
  40. JÆrgensen N, Müller J, Jaubert F, et al. Heterogeneity of gpnadoblastoma germ cells: similarities with immature germ cells, spermatogonia and testicular carcinoma in situ cels. Histopathology. 1997;30:177–186
  41. Hart AH, Hartley L, Ibrahim M, et al. Identification, cloning and expression analysis of the pluripotency promoting Nanog genes in mouse and human. Developmental Dynamics. 2004;230:187–198
  42. Hoei-Hansen CE, Almstrup K, Nielsen JE, et al. Stem cell pluripotency factor NANOG is expressed in human fetal gonocytes, testicular carcinoma in situ and germ cell tumours. Histopathology. 2005;47:48–56
  43. Giwercman A, Müller J, Skakkebæk NE. Prevalence of carcinoma-in situ and other histopathological abnormalities in testes from 399 men who died suddenly and unexpectedly. The Journal of Urology. 1991;145:77–80
  44. Giwercman A, Skakkebæk NE. Carcinoma in situ of the testis: Biology, screening and management. European Urology. 1993;23:19–21
  45. Cools M, Stoop H, Kersemaekers AM, et al. Gonadoblastoma arising in undifferentiated gonadal tissue within dysgenetic gonads. The Journal of Clinical Endocrinology and Metabolism. 2006;91:2404–2413
  46. Hannema SE, Scott IS, Rajpert-De Meyts E, et al. Testicular development in the complete androgen insensitivity syndrome. The Journal of Pathology. 2006;208:518–527
  47. Cools M, Honecker F, Stoop H, et al. Maturation delay of germ cells in trisomy 21 fetuses results in increase risk for the development of testicular germ cell tumors. Human Pathology. 2006;37:101–111
  48. Volkl TM, Langer T, Aigner T, et al. Klinefelter syndrome and mediastinal germ cell tumors. American Journal of Medical Genetics. Part A. 2006;140:471–481
  49. Aksglaede L, Wikstrom AM, Rajpert-De Meyts E, et al. Natural history of seminiferous tubule degeneration in Klinefelter syndrome. Human Reproduction Update. 2006;12:39–48
  50. Page DC. Hypothesis: a Y-chromosomal gene causes gonadoblastoma in dysgenetic gonads. Development. 1987;101(supplement):151–155
  51. Salo P, Kaariainen H, Petrovic V, et al. Molecular mapping of the putative gonadoblastoma locus on the Y chromosome. Genes Chromosomes & Cancer. 1995;14:210–214
  52. Muroya K, Ishii T, Nakahori Y, et al. Gonadoblastoma, mixed germ cell tumor, and Y chromosomal genotype: molecular analysis in four patients. Genes Chromosomes & Cancer. 1999;25:40–45
  53. Schnieders F, Dork T, Arnemann J, et al. Testis-specific protein, Y-encoded (TSPY) expression in testicular tissues. Human Molecular Genetics. 1996;5:1801–1807
  54. Hildenbrand R, Schroder W, Brude E, et al. Detection of TSPY protein in a unilateral microscopic gonadoblastoma of a Turner mosaic patient with a Y-derived marker chromosome. The Journal of Pathology. 1999;189:623–626
  55. Lau YF. Gonadoblastoma, Testicular and Prostate Cancers, and the TSPY Gene. American Journal of Human Genetics. 1999;64:921–927
  56. Lau Y, Chou P, Iezzoni J, et al. Expression of a candidate gene for the gonadoblastoma locus in gonadoblastoma and testicular seminoma. Cytogenetics and Cell Genetics. 2000;91:160–164
  57. Arnemann J, Jakubiczka S, Thuring S, et al. Cloning and sequence analysis of a human Y-chromosome-derived, testicular cDNA, TSPY. Genomics. 1991;11:108–114
  58. Zhang JS, Yang-Feng TL, Muller U, et al. Molecular isolation and characterization of an expressed gene from the human Y chromosome. Human Molecular Genetics. 1992;1:717–726
  59. Manz E, Schnieders F, Brechlin AM, et al. TSPY-related sequences represent a microheterogeneous gene family organized as constitutive elements in DYZ5 tandem repeat units on the human Y chromosome. Genomics. 1993;17:726–731
  60. Schubert S, Skawran B, Dechend F, et al. Generation and characterization of a transgenic mouse with a functional human TSPY. Biology of Reproduction. 2003;69:968–975
  61. Lau YF, Lau HW, Komuves LG. Expression pattern of a gonadoblastoma candidate gene suggests a role of the Y chromosome in prostate cancer. Cytogenetic and Genome Research. 2003;101:250–260
  62. Hahn WC, Counter CM, Lundberg AS, et al. Creation of human tumour cells with defined genetic elements. Nature. 1999;400:464–468
  63. Wright WE, Piatyszek MA, Rainey WE, et al. Telomerase activity in human germline and embryonic tissues and cells. Developmental Genetics. 1996;18:173–179
  64. Albanell J, Bosl GJ, Reuter VE, et al. Telomerase activity in germ cell cancers and mature teratomas. Journal of the National Cancer Institute. 1999;91:1321–1326
  65. Nowak R, Sikora K, Pietas A, et al. Germ cell-like telomeric length homeostasis in nonseminomatous testicular germ cell tumors. Oncogene. 2000;19:4075–4078
  66. Schrader M, Heicappell R, Muller M, et al. Molecular markers in testicular germ cell tumors–objects of clinical research or close to becoming clinical tools?. Onkologie. 2001;24:144–148
  67. Schrader M, Burger AM, Muller M, et al. Quantification of human telomerase reverse transcriptase mRNA in testicular germ cell tumors by quantitative fluorescence real-time RT-PCR. Oncology Reports. 2002;9:1097–1105
  68. Van Gurp RJLM, Oosterhuis JW, Kalscheuer V, et al. Human testicular germ cell tumors show biallelic expression of the H19 and IGF2 gene. Journal of the National Cancer Institute. 1994;86:1070–1075
  69. Looijenga LH, Gillis AJ, van Gurp RJ, et al. X inactivation in human testicular tumors. XIST expression and androgen receptor methylation status. The American Journal of Pathology. 1997;151:581–590
  70. Looijenga LHJ, Verkerk AJMH, de Groot N, et al. H19 in normal development and neoplasia. Molecular Reproduction and Development. 1997;46:419–439
  71. Looijenga LHJ, Verkerk AJMH, Dekker MC, et al. Genomic imprinting in testicular germ cell tumours. APMIS. 1998;106:187–197
  72. Sievers S, Alemazkour K, Zahn S, et al. IGF2/H19 imprinting analysis of human germ cell tumors (GCTs) using the methylation-sensitive single-nucleotide primer extension method reflects the origin of GCTs in different stages of primordial germ cell development. Genes Chromosomes Cancer. 2005;44:256–264
  73. Holm TM, Jackson-Grusby L, Brambrink T, et al. Global loss of imprinting leads to widespread tumorigenesis in adult mice. Cancer Cell. 2005;8:275–285
  74. Kersemaekers AMF, Mayer F, Molier M, et al. Role of P53 and MDM2 in treatment response of human germ cell tumors. Journal of Clinical Oncology. 2002;20:1551–1561
  75. Mayer F, Kersemaekers AM, Oosterhuis JW, et al. p53 and MDM2 in germ cell cancer treatment response. Journal of Clinical Oncology. 2002;20:3928–3929
  76. Masters JR, Koberle B. Curing metastatic cancer: lessons from testicular germ-cell tumours. Nature Reviews. Cancer. 2003;3:517–525
  77. Woods DB, Vousden KH. Regulation of p53 function. Experimental Cell Research. 2001;264:56–66
  78. Braig M, Schmitt CA. Oncogene-induced senescence: putting the brakes on tumor development. Cancer Research. 2006;66:2881–2884
  79. Voorhoeve PM, le Sage C, Schrier M, et al. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell. 2006;124:1169–1181

PII: S1521-690X(07)00038-3

doi: 10.1016/j.beem.2007.05.001

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 21, Issue 3 , Pages 480-495 , September 2007

Article Tools

* Image Usage & Resolution